Updated Guidance Issued for Management of Hep C

By on 9:55 AM

The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) have issued updated guidance on the management of hepatitis C (HCV), according to a news release.

The new guidance was posted to HCVguidelines.org, a website developed by AASLD and IDSA that provides recommendations for testing, managing and treating HCV.

The guidance reflects new testing and management recommendations specifically for pregnant women, people who inject drugs, men who have sex with men and people who are incarcerated.

The new recommendations are summarized as follows:
  • All pregnant women should be tested for HCV infection, ideally at the start of prenatal care.
  • Annual HCV testing for people who inject drugs and have never been tested for the virus, annual testing for people who have previously tested negative for the virus but continue to use injection drugs and several other recommendations for people who inject drugs.
  • For men who have sex with men, at least annual (or more often, based on risk) testing for HCV antibody for those who have never been exposed to the virus and HCV RNA testing for those who were treated for or spontaneously cleared HCV infection.
  • Jails and prisons should implement opt-out testing for incarcerated individuals and several other recommendations for people in correctional institutions.
Learn more about these updated recommendations here.

Phenelle Segal, RN, CIC, FAPIC

Phenelle Segal, RN, CIC, FAPIC, is the founder and president of Infection Control Consulting Services LLC (ICCS). Phenelle has more than 30 years' experience providing customized comprehensive infection control and prevention services to healthcare facilities nationwide. Her services focus on assisting hospitals, ambulatory surgery centers, dental office and oral surgery practices, doctor's offices, nursing homes and other organizations with implementing and maintaining an infection control program that: complies with The Joint Commission, AAAHC, Centers for Medicaid and Medicare Services (CMS) and other regulatory agencies; respond to situations of noncompliance; and improve the processes for reducing risk.